Porton Pharma Solutions

Porton Advanced provides end-to-end CDMO solutions for Advanced Therapy Medicinal Products (ATMPs), from cell banking, process and analyticals method development, cGMP production to fill&finish, covering different stages of drug development from early research, investigator-initiated trials, Investigat...

Porton Biologics and Conjugates CDMO Platform delivers one-stop drug development solution. Our expertise covers diverse modalities like ADCs, AOCs, PDCs, and RDCs.
Our core strength lies in a team of 150+ scientists. They've successfully managed 50+ projects from IND to NDA stages, serving 40+ g...

Porton Pharma is a global CDMO leader in small molecule APIs, offering efficient, flexible solutions throughout drug development—from pre-clinical to commercial production—for partners worldwide. With infrastructure exceeding 2200 m³, we support both early innovation and large-scale manufacturing....

Our platform integrates 4 R&D powerhouses: peptides, oligonucleotides and drug delivery materials, to offer end-to-end CMC solutions. From pre-clinical to commercial triumphs, we empower global clients with unparalleled expertise.
With a team of over 150 scientists, we won a robust track r...

As a global CDMO serving global innovative pharmaceutical companies and research institutions, Porton has an extensive experience in research and manufacturing services, especially in the field of PROTAC drug development. Porton is committed to the development and production of PROTAC oral formulations and provides customers with comprehensive, reliable, fast, and compliant one-stop services, to meet customers' supply chain needs and facilitating the commercial success of their products from research and development to order fulfillment.